日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density

靶向GPC2的抗体-γ/δ T细胞受体可使低抗原密度神经母细胞瘤消退

Alex Quan ,Mingyu Huo ,Dan Li ,Laura E Hutchins ,Constanza Rodriguez ,Jangsuk Oh ,Hsi-En Tsao ,Madeline Spetz ,Elijah Edmondson ,Dana Ashworth ,Rui Zheng ,Jing Zhou ,Jinyun Chen ,Jingbao Liu ,Guangyan Xiong ,Hongbing Zhang ,Cheng Liu ,Rosa Nguyen ,Nan Li ,Mitchell Ho

GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma

经NFAT诱导的膜锚定IL15/IL21改造的GPC2靶向CAR T细胞对神经母细胞瘤表现出增强的活性

Reona Okada ,Jeyshka M Reyes-González ,Constanza Rodriguez ,Taisuke Kondo ,Jangsuk Oh ,Ming Sun ,Michael C Kelly ,Ling Zhang ,James Gulley ,Jack F Shern ,Mitchell Ho ,Christian S Hinrichs ,Naomi N Taylor ,Xiyuan Zhang ,Rosa Nguyen

Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling

带有亮氨酸拉链的模块化嵌合细胞因子受体通过 JAK/STAT 信号传导增强 CAR-T 细胞的抗肿瘤活性

Matthew Bell, Shannon Lange, Besian I Sejdiu, Jorge Ibanez, Hao Shi, Xiang Sun, Xiaoxi Meng, Phuong Nguyen, Morgan Sutton, Jessica Wagner, Anil Kc, Deanna Langfitt, Sagar L Patil, Haiyan Tan, Ram Vinay Pandey, Yuxin Li, Zuo-Fei Yuan, Alejandro Allo Anido, Mitchell Ho, Heather Sheppard, Peter Vogel, 

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors

rhIL-7-hyFc 是一种长效白细胞介素 7,可提高 CAR-T 细胞治疗实体肿瘤的疗效

Dan Li, Tianyuzhou Liang, Laura E Hutchins, Alexandra A Wolfarth, Sara Ferrando-Martinez, Byung Ha Lee, Mitchell Ho

Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy

T细胞限制性IL15和IL21对CAR和TCR T细胞的协同保护作用可普遍增强实体瘤疗效

Rosa Nguyen # ,Ekaterina Doubrovina # ,Charlotte M Mousset ,Benjamin Y Jin ,Reona Okada ,Xiyuan Zhang ,Arina Clavel ,Jeyshka M Reyes-Gonzalez ,Vadim Dyomin ,Louis Diaz ,Ling Zhang ,Shahroze Abbas ,Ming Sun ,Chao-Ming Hsieh ,Mitchell Ho ,Jack F Shern ,James L Gulley ,Christian S Hinrichs

CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer

基于靶向 HPV16 E6 的 TCR 模拟纳米抗体的 CAR-T 细胞对宫颈癌表现出抗肿瘤活性

Zhijian Duan, Dan Li, Nan Li, Shaoli Lin, Hua Ren, Jessica Hong, Christian S Hinrichs, Mitchell Ho

Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice

SARS-CoV-2 刺突蛋白疫苗 S1 亚基的佐剂可改善小鼠的抗体和 T 细胞反应以及替代中和作用

William Becker, Khadija Rebbani, Zhijian Duan, Eugene Valkov, Shawn Bryant, Mitchell Ho, Jay A Berzofsky, Purevdorj B Olkhanud

The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer

IgG4铰链区与CD28跨膜结构域结合,可增强靶向胰腺癌中GPC1膜远端表位的VHH基CAR-T细胞的疗效。

Nan Li ,Alex Quan ,Dan Li ,Jiajia Pan ,Hua Ren ,Gerard Hoeltzel ,Natalia de Val ,Dana Ashworth ,Weiming Ni ,Jing Zhou ,Sean Mackay ,Stephen M Hewitt ,Raul Cachau ,Mitchell Ho

Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours

基于骆驼纳米抗体的 B7-H3 CAR-T 细胞对大型实体肿瘤表现出高效性

Dan Li, Ruixue Wang, Tianyuzhou Liang, Hua Ren, Chaelee Park, Chin-Hsien Tai, Weiming Ni, Jing Zhou, Sean Mackay, Elijah Edmondson, Javed Khan, Brad St Croix, Mitchell Ho

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma

针对神经母细胞瘤的GPC2靶向CAR T细胞疗法的临床前优化

Ming Sun ,Yingying Cao ,Reona Okada ,Jeyshka M Reyes-González ,Hannah G Stack ,Haiying Qin ,Nan Li ,Charlie Seibert ,Michael C Kelly ,Eytan Ruppin ,Mitchell Ho ,Carol J Thiele ,Rosa Nguyen